Safety and Efficacy of ARQ-151 Cream in Adolescents and Adults With Atopic Dermatitis
Condition: Atopic Dermatitis Interventions: Drug: ARQ-151 cream 0.05%; Drug: ARQ-151 cream 0.15%; Drug: ARQ-151 cream Vehicle Sponsor: Arcutis, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials